Anti-Vaccine Activists Are Now the Majority in RFK, Jr.’s CDC Vaccine Panel
Health and Human Services Secretary Robert F. Kennedy Jr. has added four right‑wing, anti‑vaccine groups as liaison members to the CDC’s Advisory Committee on Immunization Practices (ACIP). The new charter expands ACIP’s remit to probe vaccine safety gaps and cumulative effects of childhood schedules. Kennedy previously replaced all 17 original ACIP members with contrarian voices, making anti‑vaccine activists the majority on the panel.
How America’s Medical System Encourages Psychiatric Overdiagnosis
Psychiatric diagnoses in the United States have surged across all age groups, with 59.3 million adults and nearly half of adolescents meeting criteria for at least one mental disorder in 2022. Proponents argue broader criteria improve detection, yet critics contend that...
IV Vitamin Therapy Could Change Your Life — by Killing You
A Mexican IV vitamin therapy clinic in Hermosillo saw eight of 11 patients die after receiving unsupervised vitamin drips, which authorities suspect were contaminated with bacteria. The treatment, marketed as a quick fix for dehydration, fatigue, and hangovers, has been...
Generally Good Indian Pharma Companies
An audit of top‑tier Indian generic manufacturers evaluated options for 20 therapeutic compounds, ranking firms by market capitalization, API vertical integration, ANDA volume, and GMP compliance. Cipla, Abbott, Sun Pharma, Zydus, Biocon and others were highlighted for specific products such...
![She Was Learning to Keep Others Breathing While Losing Her Own Air [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/lyndsay_hoy_thumbnail.png)
She Was Learning to Keep Others Breathing While Losing Her Own Air [PODCAST]
Anesthesiologist Lyndsay Hoy, diagnosed with the rare estrogen‑sensitive lung disease LAM at 28, recounts the daunting lack of coordinated reproductive guidance for women with rare conditions. She highlights how patients become de‑facto case managers, juggling pulmonology, genetics, and reproductive specialists...
Unintended Oversights Corrected: The Real Numbers
The blog post revisits a previous analysis of VAERSAWARE.com’s reporting on child deaths with unknown ages, asserting that the true count of vaccine‑related fatalities is significantly higher than official figures. It corrects an earlier claim by emphasizing that VAERSAWARE offers...
Can Facet Arthroplasty Outperform TLIF for Spondy?
A prospective, multicenter FDA IDE trial compared the Total Posterior Spine (TOPS) facet arthroplasty system with traditional transforaminal lumbar interbody fusion (TLIF) in patients with single‑level grade I degenerative spondylolisthesis. At 24 months, TOPS achieved an 85% composite clinical success rate versus...
The Cost of Chaos in Medical Malpractice Litigation
Two recent malpractice cases illustrate how legal tactics can inflate costs. A teenage mother’s premature birth led to a $200 million plaintiff verdict that was later overturned after a two‑year appeal, revealing that delayed prenatal care, not hospital negligence, caused the...
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
Rocket Pharmaceuticals agreed to sell its rare‑pediatric disease priority‑review voucher for $180 million in cash, providing non‑dilutive funding as the PRV program was reauthorized in early 2026. Teva Pharmaceutical announced a definitive agreement to acquire Emalex Biosciences for up to $900 million,...
Senate Report: Early COVID Vaccine Warning Signs Were Overlooked
A Senate Permanent Subcommittee report alleges the FDA ignored early COVID‑19 vaccine safety signals uncovered by an alternative data‑mining method in 2021. Analyst Dr. Ana Szarfman identified dozens of statistically significant adverse‑event signals, including cardiac death and Bell’s palsy, but...
The Pharma Sovereignty Playbook: How I’m Playing the $1.5 Trillion Drug Supply Crisis
A 2023 FDA inspection of Intas Pharmaceuticals’ plant in India halted half of the U.S. cisplatin supply, triggering nationwide shortages of both cisplatin and its substitute carboplatin. The crisis highlighted that only 24% of active pharmaceutical ingredient (API) manufacturing for...
Pearl Health: The VBC Math That Should Change Your Mind
Pearl Health’s leadership shared six hard‑earned lessons on scaling value‑based care, emphasizing that real‑time claims data and benchmark design outweigh care model sophistication. They warn that without actionable insights, physicians disengage, and that the highest‑cost patients are the hardest to...
DirectorMoves – Board & C-Suite Openings
DirectorMoves, a subscription service from Directors & Boards, released its latest BoardOpenings list targeting boards with directors over age 70, no recent appointments, and those falling short of a 30% gender‑diversity threshold. The offering is gated behind a paid subscription,...
For Idiopathic Scoliosis Patients, Have You Considered Pre-Op Lung Training?
Anterior vertebral body tethering (AVBT) is gaining traction as a motion‑preserving alternative for adolescent idiopathic scoliosis, but postoperative pulmonary complications remain a concern. A retrospective review of 185 patients compared those who completed a three‑week preoperative pulmonary rehabilitation (PPR) program...
AssureCare and Pillr Health Partner to Help Health Systems Tackle Specialty Pharmacy Costs
AssureCare and Pillr Health announced a strategic partnership to embed AssureCare's Akumen analytics platform into Pillr Health's Pharmacy Accelerator solution. The integration gives hospitals real‑time data and AI‑driven predictive modeling to manage specialty pharmacy costs, which are expected to exceed...
Untangling the Web of Polypharmacy: Long-Term Care Needs Action Before Burden Turns Into Harm
Long‑term care facilities routinely conduct medication reviews, yet deprescribing remains rare because complex regimens only change after safety issues arise. A 2024 BMC Geriatrics study of 67,531 residents found an average of seven prescriptions per patient, highlighting widespread polypharmacy. Research...
March 2026 Patent Highlights
The March 2026 Patent Highlights page aggregates the latest drug‑discovery milestones, from 38 first‑time small‑molecule approvals by Europe’s EMA, China’s NMPA and Japan’s PMDA to a deep dive on protein‑structure advances and machine‑learning tools. It spotlights a newly optimized HPK1 inhibitor...
FDA Knew of Better Method to Detect COVID Vaccine Safety Signals — But Refused to Use It
Senator Ron Johnson released a report showing that FDA officials during the Biden administration knew a superior empirical Bayesian data‑mining method existed for detecting COVID‑19 vaccine safety signals in VAERS but ordered staff to continue using the older, flawed tool....
Thermo Fisher Scientific Launches Applied Biosystems PowerFlex Thermal Cycler
Thermo Fisher Scientific unveiled the Applied Biosystems PowerFlex Thermal Cycler, a next‑generation PCR instrument that emphasizes speed, precision, and flexibility. The system features a 10.1‑inch touchscreen, AI‑driven Smart Help, and two configuration options—a 96‑well plate and a 3 × 32‑well layout with...
Nanozymes Against Brain Tumors
Researchers at Empa and HOCH Health Ostschweiz are developing biocompatible nanozymes that can be applied directly during brain‑tumor surgery to attack astrocytoma cells. The nanozymes act like enzymes, generating reactive‑oxygen species and activating drug precursors, and they are triggered by...
&You Is Reimagining Access to Everyday Healthcare
&you is a digital health platform that merges telehealth consultations, prescription services, and home delivery of treatments into a single, user‑friendly experience. Founder and CEO Emil Eriksen says the service targets stigma‑laden areas such as sexual health, dermatology, and wellness,...
“Technology Needs to Enable Neighbourhood Working, Not Constrain It”
Neighbourhood care aims to integrate acute, primary, community and mental health services, but digital interoperability gaps hinder its rollout. Clinicians face duplicate data entry because systems across organisations don’t share updates. Harris Health Alliance is piloting the conneQT Toolbar, an...
Cigna's "Transparency Report" Is Just a PR Stunt
After UnitedHealthcare CEO Brian Thompson was killed, a wave of patient stories forced insurers to confront public anger. Cigna responded with a multi‑year reform agenda and released a Customer Transparency Report claiming a 15% cut in prior‑authorization volume by removing...
Winning over Medtech Investors in the Age of AI
MedTech founders are feeling squeezed by AI hype, which dominates investor dialogue. Dr. Anne Blackwood argues that investors actually value clear clinical evidence, market need, and experienced teams more than flashy AI claims. She outlines five practical steps—lead with the...
Debbie East-Nuttall | Meet the Speakers: Med-Tech Expo 2026
Debbie East‑Nuttall, Head of Medical Business Development at Kiwa, will present at Med‑Tech Expo 2026 on simplifying ISO 13485 compliance and setting realistic market‑entry timelines. Leveraging 35 years of industry experience, she will expose common pitfalls that delay approvals. The session,...
Meet the Brand New Excuse for Medical Failures; It’s a Doozy
Google AI released research indicating roughly 10% of patients may not respond to GLP‑1 weight‑loss drugs because of specific genetic variations. The finding is framed as a scientific explanation for drug inefficacy, suggesting that patient genetics, not the medication, drive...
Rethinking Prosthetics: The Challenge of Four Legged Patients
Animal prosthetics and orthotics remain a fragmented niche, demanding design approaches distinct from human care. Differences in limb biomechanics, lack of footwear, and variable ground‑reaction forces make 3D‑printed solutions far more complex to engineer. Specialists like Danielle Robins act as advisors,...
The $5B Test: Why Healthcare Compliance Programs Keep Failing the Same Way
In fiscal year 2025 the U.S. government recovered a record $6.8 billion under the False Claims Act, with $5.7 billion stemming from healthcare fraud. Despite mandatory compliance programs, many are built to pass audits rather than change behavior, leading to a surge...
Hospital Patients Can Now View Appointments in NHS App
Hospital patients at every acute NHS trust in England can now view, reschedule or cancel referrals and appointments through the NHS App, covering about 64% of all hospital bookings. The rollout adds to the 41 million registered users, with 15 million logins...
Sheffield’s New Cancer Robot Cuts Its Own Ribbon
Sheffield Hospitals Charity donated a record £1.45 million (about $1.84 million) to install a dual‑console da Vinci Xi surgical robot at Northern General Hospital. The system enables surgeons to perform minimally invasive procedures on lung, oesophageal, stomach, bowel, liver, pancreas and kidney...
Designing with Empathy: Writing Content for NHS Lung Cancer Screening
NHS England is piloting a digital version of its lung health check, a key step toward a national lung cancer screening programme slated for rollout by 2030. Over 80 users aged 50‑74 were interviewed, revealing that the word “cancer” triggers...
Start Here: What Is System C?
The blog outlines a new “System C” framework that aims to align food and healthcare around human health outcomes, targeting the $9 trillion blind spot created by chronic disease. It argues that current food (System B) and healthcare systems are optimized...
Which Supply Chains Are Most Exposed by Disruptions in The Strait of Hormuz?
Jeff Golfman, founder of Send 123, warns that disruptions in the Strait of Hormuz expose a wider contraction in global supply chains, affecting not only oil but also critical medicines. The narrow waterway, a key conduit for cargo from India, Pakistan,...
The Need for More Therapists: High Demand, AI, and Career Flexibility
Licensed Independent Clinical Social Worker Liza Brackbill launched Pathways and Possibilities Counseling Services, highlighting a surge in demand for psychotherapy, especially for anxiety‑related disorders, after the COVID‑19 pandemic. She notes that social‑media pressures and heightened awareness have expanded the client...
Bevey Miner, Consensus Cloud Solutions
Bevey Miner, EVP of Healthcare Strategy at Consensus Cloud Solutions, explained that digital cloud faxing isn’t the interoperability problem—unstructured fax data is. The company’s eFax platform now includes an AI‑driven extraction engine called Clarity, which converts PDFs, TIFFs and scanned...
The Resurrectionists: Grave Robbers Who Built Modern Medicine
In 18th‑ and 19th‑century Britain, illegal grave‑robbing gangs called Resurrectionists supplied fresh cadavers to anatomy schools, filling a critical shortage for medical training. Their organized operations could harvest up to six bodies a night, with a single corpse fetching as...
Word Games: How Moderna Is Selling Its Newest Vaccine without Using the “V” Word
Moderna’s $776 million federal award for a bird‑flu vaccine is under scrutiny after U.S. officials targeted mRNA technology, prompting the company to warn it may halt late‑stage vaccine programs. Simultaneously, Moderna and Merck are advancing an mRNA‑based cancer treatment, which Merck...
Viewpoint: Health Experts Engage MAHA: Shared Concerns, Differing Views on What Constitutes Evidence
At a national public‑health meeting, MAHA leaders joined physicians and public‑health professionals for a rare, good‑faith dialogue about evidence and communication. The MAHA speakers relied heavily on storytelling, while the health experts emphasized data‑driven logic. The discussion highlighted that effective...
CRL Release Update – No Litigation War yet, but New Citizen Petition Beats the Drums
The FDA has begun posting Complete Response Letters (CRLs) for unapproved NDAs, ANDAs, and BLAs, releasing 127 documents to date, including 36 that had never been publicly disclosed. A Washington‑based law firm filed a Citizen Petition on April 20, 2026,...
Why Are Americans in One Region Dying Years Earlier Than Rest of Country?
A recent analysis highlights that residents of several Southern states—Mississippi, Louisiana, Alabama, South Carolina, Kentucky, Arkansas and Tennessee—die 5‑10 years earlier than the national average. The gap is linked to higher rates of chronic diseases, rural hospital closures, limited preventive...
![He Declined Routine X-Rays and Was Denied a Dental Cleaning [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/18cacd38-6c3b-419c-8d97-fab1cca74be2.png)
He Declined Routine X-Rays and Was Denied a Dental Cleaning [PODCAST]
Patient advocate Aaron Rosenberg was denied a routine dental cleaning after refusing non‑mandatory bite‑wing X‑rays, despite recent imaging and low risk. The clinic cited a licensure risk and an internal policy, though the ADA does not require such X‑rays for...
How AI, Value Based Care Bundles, Medicare Payment Compression, and IMG-Driven Residency Match Dynamics Will Reshuffle the Wealthiest Physician Specialty...
Four converging forces—AI augmentation, mandatory value‑based care bundles, ongoing Medicare fee‑schedule compression, and tightening IMG‑driven residency pipelines—are set to reshape the hierarchy of physician specialty earnings by 2030‑35. AI tools are boosting productivity in radiology, pathology and anesthesia while modestly...
Peptides / Bioregulators
The AGI House in San Francisco hosted the inaugural California Peptide Club, drawing over 100 invite‑only attendees to discuss self‑optimization peptides. Organiser Julius Ritter highlighted the fragmented information landscape and showcased stacks ranging from growth‑hormone releasers to cognitive enhancers. Days later, HHS...
FOXO4-DRI Is Fascinating, but Was Never Intended for Human Use, What Are the Takeaways?
FOXO4‑DRI is an experimental senolytic peptide that selectively eliminates senescent cells by disrupting the FOXO4‑p53 interaction, prompting p53‑mediated apoptosis. Pre‑clinical studies across vascular, reproductive, musculoskeletal and renal models report improved endothelial function, restored testosterone production, chondrocyte rejuvenation, and reduced frailty....
Peptides / Bioregulators
A new study examined 6,441 gray‑market peptide samples covering 14 compounds, measuring purity, dose accuracy, and endotoxin levels. Between 41.6% and 71.1% of the products failed basic pharmaceutical standards, and 2.4% contained no active peptide at all. Endotoxin contamination appeared...
Semiglutide Regenerates Cartilage Loss Through Weight Loss Independent Metabolic Restoration Mechanism
Semaglutide, a GLP‑1 receptor agonist originally developed for diabetes, is showing promise as a cartilage‑regenerating therapy. Preclinical pair‑fed mouse studies demonstrate cartilage protection independent of weight loss, while a 24‑week pilot in humans reported a 17% increase in cartilage thickness....
Why Patient Understanding Is the Missing Metric in Medicine
Physician Joseph Rotella argues that patient understanding is the lone unmeasured metric in modern healthcare. He proposes a brief, standardized teach‑back moment at the end of every visit to confirm patients can articulate their care plan. The article highlights how...
MDaudit Launches “Revenue Integrity Redefined” To Help Healthcare Organizations Reclaim Financial Control
MDaudit unveiled its "Revenue Integrity Redefined" campaign, a suite of AI‑driven tools and a maturity‑assessment resource aimed at moving health‑system revenue cycles from reactive denial handling to proactive risk control. The platform’s Meaningful AI framework embeds intelligence across coding, billing...
HIV Drug (Maraviroc) Reverses Muscle Aging by Purging “Zombie Cell” Signals
Researchers are exploring the HIV CCR5 antagonist maraviroc as a senomorphic agent that could blunt muscle aging by dampening chronic SASP signaling. Modeling suggests a 75 mg once‑daily dose achieves high CCR5 occupancy, but human data on sarcopenia are absent. The...
The IPO Buzz: Biotechs Back in Play
Biotech IPO activity revives as three companies—Avalyn Therapeutics, Hemab Therapeutics, and Seaport Therapeutics—file to raise a combined $601.1 million. Each plans to sell 11.8 million shares within a $16‑$18 price band, targeting roughly $200 million per offering. The deals follow a recent pulmonary‑fibrosis...